Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Mecapegfilgrastim

No overview information available.

No background information available.

用于成年非髓性恶性肿瘤患者在接受容易引起发热性中性粒细胞减少症的骨髓抑制性抗癌药物治疗时，降低以发热性中性粒细胞减少症为表现的感染发生率。本品不用于造血干细胞移植的外周血祖细胞的动员。

No associated conditions information available.

Phase 2

Not yet recruiting

Posted: 2024/11/12

Phase 2

Active, not recruiting

Posted: 2022/07/19

Phase 2

Posted: 2020/07/07

Not Applicable

Posted: 2019/11/21

No FDA products found for this drug

No Singapore products found for this drug

No news found

Stay informed with timely notifications on clinical trials and research advancements.